Research has linked many drugs to QT prolongation and decision support tools could alert clinicians to the risk and guide prescribing decisions to safer alternatives.
Joan Kapusnik-Uner, Pharm.D., FCSHP, FASHP
Advertisement
Articles by Joan Kapusnik-Uner, Pharm.D., FCSHP, FASHP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
WeightWatchers Launches Employer Program for GLP-1 Drugs
2
Ergonomics, Independence and Inclusion Take Center Stage | AAO 2025
3
Professional Pickleball Players Most Likely to Sustain Eye Injury, Least Likely to Wear Eye Protection, Survey Shows | 2025 AAO
4
The Next Breakthrough in Schizophrenia Could be a Digital Therapeutic
5
